GlaxoSmithKline PLC
Broker Recommendation (11 Brokers)GlossaryGo to Portfolio
STRONG SELL
STRONG BUY
HOLDSTRONG BUY| 2010 | 2011 | |||||
|---|---|---|---|---|---|---|
| Pre-tax (£) | EPS (p) | DPS (p) | Pre-tax (£) | EPS (p) | DPS (p) | |
| Consensus | 8,463.00 | 120.26 | 64.70 | 9,506.00 | 119.66 | 73.90 |
| 1 Month Change | -408.22 | -1.14 | -0.27 | 95.41 | -3.43 | 4.29 |
| 3 Month Change | -346.72 | -2.11 | -0.74 | 95.56 | -3.68 | 3.82 |
| 2009 (A) | 2010 (E) | 2011 (E) | ||
|---|---|---|---|---|
| Norm. EPS | % | -3.54 | 13.15 | -0.50 |
| DPS | % | 7.27 | 9.66 | 14.22 |
| 2009 (A) | 2010 (E) | 2011 (E) | ||
|---|---|---|---|---|
| EBITDA | £m | 10,323.00 | 10,486.40 | |
| EBIT | £m | 9,462.80 | 8,646.60 | |
| Dividend Yield | % | 4.84% | 5.31% | 6.06% |
| Dividend Cover | x | 1.80 | 1.86 | 1.62 |
| PER | x | 11.47 | 10.14 | 10.19 |
| PEG | f | -3.24 | 0.77 | -20.42 |
| Net Asset Value PS | p | 223.72 | 270.29 | |
Brokers
The consensus above is compiled from contributions by the following brokers:
WestLB, SG Securities, Exane BNP Paribas, Panmure Gordon, Charles Stanley, Shore Capital, Evolution Securities Ltd, Collins Stewart, ABN AMRO, Nomura Research Institute, Fyshe Horton Finney Ltd
WestLB, SG Securities, Exane BNP Paribas, Panmure Gordon, Charles Stanley, Shore Capital, Evolution Securities Ltd, Collins Stewart, ABN AMRO, Nomura Research Institute, Fyshe Horton Finney Ltd